Fig. 1
From: Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
FDA and CFDA approved inhibitors of the epigenetic targets
Fig. 1 | Journal of Biomedical Science
From: Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
FDA and CFDA approved inhibitors of the epigenetic targets
Journal of Biomedical Science